Concepedia

Author

Seiko Yoshida

National Hospital Organization Hanamaki Hospital

Also Known As

Seiko YOSHIDA, Seiko Yoshida, Shizuka Asada

10

Publications

1.1K

Citations

6

H-Index

10

Concepts

All Affiliations

National Hospital Organization Hanamaki HospitalFondazione IRCCS Istituto Neurologico Carlo BestaAlexion Pharmaceuticals (United States)International University of Health and WelfareRigshospitalet
SY

About

Seiko Yoshida is an author at National Hospital Organization Hanamaki Hospital specializing in medicine, immunology, and autoimmune disease.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

986

2

Immunology

1

1

14

3

Pharmacology

1

1

745

4

Autoimmune Disease

1

1

14

5

Clinical Trials

1

1

227

Seiko Yoshida

×

5

Publications

1.1K

Citations

5

H-Index

YearCitations

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar,

The Lancet Neurology

2017

745

Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

Vera Bril, Artur Drużdż, Julian Großkreutz,

The Lancet Neurology

2023

227

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi,

Neurology

2020

74

Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study

Hiroyuki Murai, Akiyuki Uzawa, Yasushi Suzuki,

Journal of the Neurological Sciences

2019

23

Psoriasis Improved by Intravenous Immunoglobulin Therapy

Yoshiharu Taguchi, Shutaro Takashima, Seiko Yoshida,

Internal Medicine

2006

14

Page 1